Strode Discusses Rise in Surgery Center Transactions with Becker’s ASC Review
06 September 2019
Partner Roger Strode was featured in a Becker’s ASC Review interview about the factors fueling the current rise in ASC activity.
Strode told Becker’s that the move out of acute care hospital facilities and toward outpatient facilities is fueling ASC activity. “ASCs continue to be the most cost-efficient and patient-friendly environments available. CMS continues to expand the list of covered ASC surgical procedures, with eight proposed procedures to add to the ASC list of covered surgical procedures in 2020. These new additions include total knee arthroplasty, a mosaicplasty procedure, as well as six coronary intervention procedures,” he said. “We are also seeing continued interest from hospitals in partnering with physicians in ASC deals, to recapture volume previously lost to physician-only ASC projects and/or to enhance relationships with local physicians. Finally, we see increasing ASC activity as private equity investors continue to acquire proceduralists such as ophthalmologists, gastroenterologists and orthopodiatrists”
Read the complete interview here.
Strode told Becker’s that the move out of acute care hospital facilities and toward outpatient facilities is fueling ASC activity. “ASCs continue to be the most cost-efficient and patient-friendly environments available. CMS continues to expand the list of covered ASC surgical procedures, with eight proposed procedures to add to the ASC list of covered surgical procedures in 2020. These new additions include total knee arthroplasty, a mosaicplasty procedure, as well as six coronary intervention procedures,” he said. “We are also seeing continued interest from hospitals in partnering with physicians in ASC deals, to recapture volume previously lost to physician-only ASC projects and/or to enhance relationships with local physicians. Finally, we see increasing ASC activity as private equity investors continue to acquire proceduralists such as ophthalmologists, gastroenterologists and orthopodiatrists”
Read the complete interview here.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”